Edwards Lifesciences affirmed FY2025 adjusted EPS guidance of $2.40-$2.50 and raised FY2025 sales guidance from $5.70 billion ...

Eli Lilly's donanemab gets CHMP backing for early Alzheimer's in select patients after trials show reduced disease ...

Despite XRP's (CRYPTO: XRP) recent price cooldown, market commentators remain optimistic about XRP, boosted by growth in ...

Blackstone reported second-quarter fiscal year segment revenues of $3.075 billion, up 22% Y/Y, beating the analyst consensus ...

The company reported an adjusted loss of 42 cents per share, wider than Wall Street's projected 12-cent loss, according to ...

They didn't make six figures out of the gate. They weren't pulling in $300,000 tech salaries or inheriting money. But many ...

Charter reported quarterly revenue growth of 0.6% year-on-year to $13.77 billion, beating the analyst consensus estimate of ...

Coursera reported quarterly earnings of 12 cents per share, which beat the analyst consensus estimate of nine cents.

Centene reported a Q2 loss and pulled its 2025 guidance despite rising revenue, citing higher healthcare costs and shifting ...

Defense contractor Booz Allen Hamilton Holding (NYSE: BAH) reported strong fiscal first-quarter results, exceeding analyst ...

As of July 25, 2025, two stocks in the materials sector could be flashing a real warning to investors who value momentum as a ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, ...